EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication

Title
EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication
Authors
Keywords
HNSCC; Erlotinib; IHC; MSD; Tyrosine Kinase Inhibitor
Journal
Oncotarget
Volume 9, Issue 48, Pages -
Publisher
Impact Journals, LLC
Online
2018-06-22
DOI
10.18632/oncotarget.25656

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now